Assertion: polypeptide | /r/HasAspect | the amino acid sequence
Facets:
value: according to seq id no
type: OTHER
value: in one embodiment
type: LOCATION
value: specifically
type: MANNER
value: completely
type: DEGREE
Source sentences:
text: Since the polypeptide has the amino acid sequence, the polypeptide can act on a receptor TMM on undifferentiated epidermal cells and promotes differentiation from the undifferentiated epidermal cells into guard cells which constitute a stoma in a plant, thereby increasing the density of stomata in the plant.
text: Typically, a polypeptide of the invention encodes a polypeptide having at least alpha-galactosidase activity, tentatively called TEMER02362, having an amino acid sequence according to SEQ ID NO: 17, or a sequence which is a variant thereof, typically functionally equivalent to the polypeptide having the sequence of SEQ ID NO: 17, or a sequence which is a fragment of either thereof.
text: The two third polypeptides may have completely the same amino acid sequence (may have binding activity against the same antigen).
text: In one embodiment the polypeptide has the amino acid sequence as set forth in any of SEQ ID
text: In one embodiment the polypeptide has the amino acid sequence as set forth in any of SEQ ID
text: In one embodiment the polypeptide has the amino acid sequence as set forth in any of SEQ ID NOS: 1, 3-7, or 9-11, including fragments, mutants, variants, analogs, or derivatives, thereof.
text: This invention provides a vaccine which comprises the polypeptide having the amino acid sequence as set forth in any of SEQ ID NOS: 1, 3-7,9-11, 22, and 23 and a pharmaceutically acceptable adjuvant or carrier.
text: This invention provides a vaccine which comprises the polypeptide having the amino acid sequence which comprises a conserved region as set forth in FIG.
text: The present invention further provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2, but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 13.
text: The present invention further provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2, but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 13.
text: Similarly, the present invention provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4 but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 14.
text: Similarly, the present invention provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4 but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 14.
text: In a particular embodiment, a polypeptide that binds to the polypeptide having the amino acid sequence set forth in SEQ ID NO: 2 but does not bind to the polypeptide having the amino acid sequence set forth in SEQ ID NO: 13 or has the amino acid sequence set forth in SEQ ID NO: 4.
text: One aspect of the invention provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2, but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 13.
text: One aspect of the invention provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2, but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 13.
text: Another aspect of the invention provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4 but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 14.
text: Another aspect of the invention provides an isolated antibody or fragment thereof that binds to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4 but does not bind to a polypeptide having the amino acid sequence set forth in SEQ ID NO: 14.
text: Typically, a polypeptide of the invention encodes a polypeptide having at least alpha-galactosidase activity, tentatively called TEMER08862, having an amino acid sequence according to SEQ ID NO: 22, or a sequence which is a variant thereof, typically functionally equivalent to the polypeptide having the sequence of SEQ ID NO: 22, or a sequence which is a fragment of either thereof.
text: Typically, a polypeptide of the invention encodes a polypeptide having at least xyloglucanase activity, tentatively called TEMER04790, having an amino acid sequence according to SEQ ID NO: 27, or a sequence which is a variant thereof, typically functionally equivalent to the polypeptide having the sequence of SEQ ID NO: 27, or a sequence which is a fragment of either thereof.
text: Typically, a polypeptide of the invention encodes a polypeptide having at least alpha-arabinofuranosidase activity, tentatively called TEMER06848, having an amino acid sequence according to SEQ ID NO: 37, or a sequence which is a variant thereof, typically functionally equivalent to the polypeptide having the sequence of SEQ ID NO: 37, or a sequence which is a fragment of either thereof.
text: Typically, a polypeptide of the invention encodes a polypeptide having at least endo-xylanase activity, tentatively called TEMER03124, having an amino acid sequence according to
text: Typically, a polypeptide of the invention encodes a polypeptide having at least alpha-glucuronidase activity, tentatively called TEMER07305, having an amino acid sequence according to SEQ ID NO: 72, or a sequence which is a variant thereof, typically functionally equivalent to the polypeptide having the sequence of SEQ ID NO: 72, or a sequence which is a fragment of either thereof.
text: In one embodiment, the polypeptide has an amino acid sequence which is a conserved region as determined in reference to a consensus sequence set forth in FIG.
text: In one embodiment, the polypeptide has an amino acid sequence which is a conserved region as set forth in FIG.
text: In one embodiment, the polypeptide has an amino acid sequence which is a conserved region as set forth in FIG.
text: mRNA.polypeptide copolymer is a macromolecular complex including an mRNA and a polypeptide having an amino acid sequence encoded by the attached mRNA.
text: mRNA·polypeptide copolymer is a macromolecular complex including an mRNA and a polypeptide having an amino acid sequence encoded by the attached mRNA.
text: mRNA·polypeptide copolymer is a macromolecular complex including an mRNA and a polypeptide having an amino acid sequence encoded by the attached mRNA.
text: Alternatively, it may have two or more activities while having the same amino acid sequence (for example, it may have binding activity to two or more different antigens).
text: Specifically, for example, when the polypeptide multimer of the present invention is a bispecific antibody in which the L chain is shared (the third polypeptide and the fourth polypeptide have the same amino acid sequence), Polypeptide multimers can be produced or purified by the following method.